Hillstream Biopharma Stock Number Of Shares Shorted
Hillstream Biopharma fundamentals help investors to digest information that contributes to Hillstream Biopharma's financial success or failures. It also enables traders to predict the movement of Hillstream Stock. The fundamental analysis module provides a way to measure Hillstream Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hillstream Biopharma stock.
Hillstream |
Hillstream Biopharma Company Number Of Shares Shorted Analysis
Hillstream Biopharma's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current Hillstream Biopharma Number Of Shares Shorted | 52.74 K |
Most of Hillstream Biopharma's fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hillstream Biopharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
CompetitionBased on the recorded statements, Hillstream Biopharma has 52.74 K of outstending shares currently sold short by investors. This is 98.35% lower than that of the Biotechnology sector and 98.97% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 98.88% higher than that of the company.
Hillstream Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hillstream Biopharma's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hillstream Biopharma could also be used in its relative valuation, which is a method of valuing Hillstream Biopharma by comparing valuation metrics of similar companies.Hillstream Biopharma is currently under evaluation in number of shares shorted category among its peers.
Hillstream Fundamentals
Return On Equity | -1.47 | |||
Return On Asset | -0.78 | |||
Current Valuation | 496.66 K | |||
Shares Outstanding | 17.53 M | |||
Shares Owned By Insiders | 38.90 % | |||
Shares Owned By Institutions | 0.80 % | |||
Number Of Shares Shorted | 52.74 K | |||
Price To Book | 0.88 X | |||
EBITDA | (6.88 M) | |||
Net Income | (8.47 M) | |||
Cash And Equivalents | 9.48 M | |||
Cash Per Share | 0.82 X | |||
Total Debt | 772.9 K | |||
Current Ratio | 13.13 X | |||
Book Value Per Share | 0.18 X | |||
Cash Flow From Operations | (6.56 M) | |||
Short Ratio | 0.20 X | |||
Earnings Per Share | (0.76) X | |||
Target Price | 4.0 | |||
Market Capitalization | 4.23 M | |||
Total Asset | 6.69 M | |||
Retained Earnings | (15.38 M) | |||
Working Capital | 5.54 M | |||
Z Score | -2.34 | |||
Net Asset | 6.69 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Hillstream Stock
If you are still planning to invest in Hillstream Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hillstream Biopharma's history and understand the potential risks before investing.
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |